Work

Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer with Bone Metastases

Year: 2007

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-07-1269

Authors: Paul Mathew, Peter F. Thall, Corazon D. Bucana, William K. Oh, Michael J. Morris, Donnah M. Jones, Marcella M. Johnson, Sijin Wen, Lance C. Pagliaro, Nizar M. Tannir, Shi-Ming Tu, Anthony A. Meluch, Lon Smith, Lorenzo Cohen, Sun-Jin Kim, Patricia Troncoso, Isaiah J. Fidler, Christopher J. Logothetis

Institutions: The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Sarah Cannon

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: G4872537112, University of Texas SPORE in Prostate Cancer

OpenAlex ID: W2118628551

FWCI: 6.874

Cites: 34

Cited by: 88

Related to: 10